Clinical and prognostic significance of serum MMP-9, endostatin and VEGF in patients with advanced non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 10, Issue 2, 2007, Pages 138-140

  Li, Xuebing ^a   Li, Baolan ^a   Lai, Baitang ^a   Zhang, Xinyong ^a   Ge, Qiping ^a   Zhan, Xiuping ^a   Wang, Yue ^a   Zhu, Yunzhong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Non small cell lung cancer; Prognosis; Tumor marker

Indexed keywords

ANTINEOPLASTIC AGENT; ENDOSTATIN; GELATINASE B; VASCULOTROPIN;

ACUTE DISEASE; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LUNG DISEASE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 34247491156     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst, 1997,89(17): 1260-1270.
2. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997,88(2): 277-285.
3. Borgstrom P, Hillan KJ , Sriramarao P, et al. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res, 1996,56 (17):4032-4039.
4. Laack E, Kohler A, Kugler C, et al. Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer. Ann Oncol, 2002,13(10):1550-1557.
5. Suzuki M, Iizasa T, Ko E, et al. Serum endostatin correlates with progression and prognosis of non-small cell lung cancer. Lung Cancer, 2002,35(1):29-34.
6. Swinson DE, Jones JL, Richardson D, et al. Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables. Lung Cancer, 2002,37(3):235-240.
7. Fontanini G, Faviana P, Lucchi M, et al. A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma. Br J Cancer, 2002,86(4):558-563.
8. Liao ML, Wang HM, Lin ZQ, et al. Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer. Lung Cancer, 2001,33 (2-3):125-132.